FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

SEC EDGAR CompanyFacts fact · reporting period

Revance Therapeutics, Inc.: capex

One fact, its scope and the complete path back to the official record.

Period: 2022-01-01 – 2022-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/ed236236-b180-4505-af22-8204cd8d6feb

Reported value

$1.456M{"amount": 1456000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Entity
Revance Therapeutics, Inc.
Metric
capex
Period
2022-01-01 – 2022-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-22-146362 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T14:41:26.423200+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001479290/capex/2022-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.

All facts for this organization →Query facts through API / MCP →Versioning policy →
From the Record
18% of job ads mention AI. Only 2% are AI jobs — and two thirds of the mentions come from 22 companies that say it in every ad.
Read the findingSearch 53 million companies